Details of the Drug Reposition

General Information of This Drug (ID: DM6IQ3V)

• Drug Name: IMO-2055 (DM6IQ3V)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 2	[1]
Renal cell carcinoma	DISQZ2X8	2C90	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of Idera Pharmaceuticals (2011).